NEWS
People
Cancer Research UK and the University of Cambridge have appointed Greg Hannon as the new director of the Cancer Research UK Cambridge Institute. Hannon takes over from Simon Tavaré who has led the Institute since 2006. Hannon has a long history in the discovery of cancer genes, and has developed widely used tools and strategies for manipulating gene expression in mammalian cells and animals.
Cell-based gene therapeutics company, apceth Biopharma has appointed a new supervisory board, responsible for advising and supporting the company on its corporate and business strategies. The new board comprises Manfred Ruediger, chairman, with expertise in advancing cell-based therapies towards late-stage clinical development; Hans-Jochem Kolb, a pioneer in cellular immunotherapy and bone marrow/ stem cell transplantation; Matthias Kromayer, a member of the executive board of venture capital company MIG Verwaltungs; and Klaus Schollmeier, who has more than 30 years’ experience as a senior executive and advisor in the biotech industry as well as in investment banking.
Global life sciences company, Bayer has appointed Nestlé’s Heiko Schipper to its management board and head of the consumer health division, which is headquartered in Basel, Switzerland. He succeeds Erica Mann.
Irish headquartered global biopharmaceutical company, Shire has appointed Bayer’s Andreas (Andy) Busch, as executive VP, head of R&D, and CSO, and will become a member of the company’s executive committee. Howard Mayer, currently serving as Shire’s head of R&D has been appointed CMO.
Oxford-based biotech, Evox Therapeutics, which focuses on engineering exosome therapeutics, has appointed Antonin de Fougerolles as CEO. He takes over from acting CEO Per Lundin, who will continue in his role as COO.
US-based nutrition and animal health company Diamond V has appointed Evan Chaney, as director, food safety micro- biology. Chaney was previously director, customer applications and microbiology at Roka Bioscience, and has experience of food safety test method applications across the industry. The company has also appointed Karen Lehe director, swine business development, to lead this sector in the US.
Early stage biotech, Exonate has formed a clinical advisory board (CAB) to support the development of an eye-drop treatment for retinal vascular diseases. The CAB comprises Pete Adamson, head of ophthalmology R&D at ProQR Therapeutics; Lloyd Paul Aiello, professor of ophthalmology at Harvard Medical School, US; Peter Campochiaro, professor of ophthalmology and neuroscience at the Johns Hopkins Wilmer Eye Institute in Baltimore, Maryland, US; Usha Chakravarthy, professor in the Institute for Ophthalmology and Vision Science at Queen’s University, Belfast; Robyn Guymer, professor of ophthalmology at Melbourne University, Australia and deputy director of the Centre for Eye Research Australia.
Jerusalem-headquartered Gamida Cell, a cellular and immune therapeutics company, has appointed Julian Adams as chairman and CEO. Adams, who has over 30 years’ drug discovery and development experience, succeeds Yael Margolin, who will remain as president.
Swedish biopharmaceutical company, Hansa Medical, on the sudden death of CEO Göran Arvidson, has appointed chairman of the company Ulf Wiinberg as acting CEO, and board member Birgit Stattin Norinder as chairman until further notice.
The Engineering Construction Industry Training Board (ECITB), the statutory skills body for the engineering construction industry (ECI) in the UK, has appointed geophysicist Lynda Armstrong as its new chair. Since her retirement from Shell International, Armstrong has held several positions on boards as a non-executive director; she also chairs the British Safety Council.
Pertinax Pharma, a spin out from the University of Bristol, UK, has appointed Nigel Brooksby as chairman. Former chairman of Sanofi, Brooksby has had a 38-year career in the pharma industry and is expected to take the company through the commercialisation of its propriety antimicrobial technology.
Realm Therapeutics, a clinical stage biopharmaceutical company focusing on immunomodulatory technology, has appointed Sanford Zweifach as a non-executive director. In addition, current non-executive directors, Matthew Hammond and Daniel Hegglin, will retire from the board.
UK-based epigenetic technologies company Cambridge Epigenetix, has appointed Mark Dawson to its scientific advisory board (SAB). Dawson has experience in the translation of cancer epigenetics research to clinical practice.
Chris Hewett has been appointed as CEO of the UK’s Solar Trade Association (STA). He replaces Paul Barwell, who retires in January 2018. Hewett has been leading on policy for the STA since June, having previously headed up the Environment Agency’s climate change team. Leonie Greene has been promoted to a director role in the organisation.
Alan Dickson, professor of biotechnology at the University of Manchester, UK, is the winner of this year’s Peter Dunnill Award, acknowledging his lifetime contribution to bioprocessing. Mark Bustard, business development director at the National Biologics Manufacturing Centre, CPI, is the recipient of the Richard Wilson Impact Award that acknowledges individuals or groups who are making an impact on the bioprocessing sector.
Global healthcare company BTG, based in the UK, has appointed Duncan Kennedy as CFO, succeeding Rolf Soderstrom. Kennedy currently leads BTG’s interventional oncology business. In addition, Gregory Barrett has been appointed a non-executive director. Barrett joins with a background in the US medtech industry.
14 10 | 2017
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
